Barclays PLC Astrazeneca PLC Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $6.07 Million - $7.35 Million	90,900 New	90,900 $7.09 Million
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $443,303 - $511,736	-9,400 Reduced 75.2%	3,100 $154,000
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $456,402 - $525,460	-8,600 Reduced 40.76%	12,500 $685,000
Q2 2020 Aug 12, 2020	SELL	$43.1 - $55.31 $409,450 - $525,445	-9,500 Reduced 31.05%	21,100 $1.12 Million
Q1 2020 May 13, 2020	SELL	$37.79 - $51.33 $1.53 Million - $2.07 Million	-40,400 Reduced 56.9%	30,600 $1.37 Million
Q4 2019 Feb 10, 2020	BUY	$42.46 - $50.46 $161,348 - $191,748	3,800 Added 5.65%	71,000 $3.54 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $6.65 Million - $7.53 Million	-165,700 Reduced 71.15%	67,200 $3 Million
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $9.01 Million - $10.1 Million	-241,600 Reduced 50.92%	232,900 $9.61 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $14.5 Million - $17.6 Million	408,400 Added 617.85%	474,500 $19.2 Million
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $600,818 - $676,287	-16,300 Reduced 19.78%	66,100 $2.51 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $1.01 Million - $1.15 Million	-29,000 Reduced 26.03%	82,400 $3.26 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $2.89 Million - $3.1 Million	83,600 Added 300.72%	111,400 $3.91 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $1.96 Million - $2.17 Million	-59,300 Reduced 68.08%	27,800 $972,000
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $2.01 Million - $2.18 Million	-62,700 Reduced 41.86%	87,100 $3.02 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $4.34 Million - $5.09 Million	149,800	149,800 $5.08 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.21 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.81 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.49 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.46 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.28 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $207B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account